Becker’s Hospital Review has named
Cheryl Sadro, CPA, executive vice president and chief business and finance officer at UTMB, one of its “130 Women Hospital and Health System Leaders to Know.” The annual list recognizes leaders for their management and leadership skills, as well as career accomplishments. Sadro joined UTMB in 2014 and has more than 30 years of experience in public accountancy and financial leadership roles at major mission-based health systems.
Jeff Farroni, PhD, JD, was named UTMB’s director of Clinical Ethics for the Health System and joins the faculty in the Department of Preventive Medicine and Community Health. Farroni will provide leadership and direction for the Ethics Program, including the Ethics Consultation Service and the Ethics Committee. He comes to UTMB after serving as a clinical ethicist and assistant professor at the University of Texas MD Anderson Cancer Center. He received a PhD in Medical Sciences from Texas A&M University, a Juris Doctor from the University of Houston and post-doctoral training at UTMB in both clinical and research ethics.
Craig Cassidy, MHA, has been named associate director of Research
Advancement. In this role, Cassidy will help faculty members develop new applications for extramural funding or revise those previously submitted. He’ll also help develop multi-investigator and multidisciplinary applications.Cassidy has served in various leadership roles in higher education for more than a decade, including as assistant dean for Research, Corporate Relations and Diversity for the College of Science, Engineering and Technology at Jackson State University; executive director of Research and Diversity Initiatives for the University of Houston System; and assistant director for the Center for Structural Biology at Texas A&M University.
Krista Versteeg, a Microbiology and Immunology graduate student at UTMB, has been named a 2016 Emerging Leader in Biosecurity Initiative Fellow by the UPMC Center for Health Security. Versteeg is one of 28 fellows chosen from around the world.The 2016 ELBI class will engage with influential leaders in the field of biosecurity through a series of meetings and candid discussions on issues that are critical to the future of work in this area. The program lasts throughout the year and will begin with a Washington, DC workshop in March.
UTMB Physician Assistant students were recently presented with the Texas Academy of Physician Assistants PA Day at the Capitol Award for best student participation at the March 2015 Legislative Day at the 41st TAPA Spring CME Conference in Houston. More than 50 UTMB Physician Assistant students traveled to Austin last year to meet with legislators regarding Physician Assistant bills and issues, and to learn more about the legislative process. This is the first time the award has been presented. UTMB will hold the award for the next two years.
Rachel Murray, business manager for Transplant Services, was presented with the Early Career Healthcare Executive Regent’s Award by the American College of Healthcare Executives. ACHE is an international professional society of 40,000 health care executives who lead hospitals, health care systems and other health care organizations.
Scott Weaver, PhD, Nikos Vasilakis, PhD, and
Dr. George Saade participated in a workshop on the Zika virus organized by the National Academies of Sciences, Engineering and Medicine in Washington, DC. As infectious disease and maternity care experts, they were part of a daylong discussion on Zika and its effects. The virus has spread nearly unabated through parts of the world, including South and Central America, and has been linked to birth defects and neurological ailments.
Jill Bryant-Bova, a quality management specialist in Quality and Healthcare Safety, recently published “Improving Chemotherapy Ordering Process” in the Journal of Oncology Practice. Chemotherapy is a high-risk medication and is the second most common cause of fatal medication errors. Read the full abstract to learn how she increased quality through education and standardization of the chemotherapy ordering process.